Primary Postpartum Hemorrhage Control Using Intrauterine Misoprostol plus Intravenous Oxytocin in Cesarean Section

Abstract

Postpartum hemorrhage (PPH) finding more methods either pharmacologic or nonpharmacologic to such a tragic event should be exceedingly invigorated to minimize
the mortality and morbidity. Every attempt should be done towards the prevention of
PPH. Of course, the use of oxytocin did such, but in spite of that, still, about half a
million deaths each year from pregnancy and delivery complication most of them are
in the third world. PPH comes as a leading cause of the maternal loss. Needless to
say, that blood loss in women who's their iron stores are already severely depleted
have more morbidity and mortality. Many uterotonics have been evaluated for years
for the prevention of PPHand efforts have been done to improve the preventive
measures for PPH which finalized in 2012 by the addition of misoprostol as an
alternative for oxytocin.
This study aimed to review Postpartum Hemorrhage Control Using Intrauterine
Misoprostol plus Intravenous Oxytocin duringCesarean Section.